Methadone clinics show mixed progress two years after regulatory overhaul

In 2024 the federal government revised rules for opioid addiction treatment centers, giving them more leeway to provide take‑home methadone doses and removing the requirement that patients attend counseling as a condition for medication.

Early data collected by industry groups and federal agencies indicate that a growing share of clinics are offering take‑home medication, but the extent of adoption varies widely across states and providers.

Analysts say the regulatory shift has sparked a cultural conversation, yet many clinics have not fully embraced the new flexibility, leaving the overall impact on patient access and outcomes still uncertain.